News from milliporesigma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 19, 2019, 08:00 ET MilliporeSigma Granted 20 CRISPR Patents Total Worldwide

MilliporeSigma, a leader in genome editing, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have...


Jul 18, 2019, 08:00 ET MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

MilliporeSigma and the Broad Institute of MIT and Harvard today announced an agreement to offer non-exclusive licenses to CRISPR intellectual...


Jun 20, 2019, 13:30 ET Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named 'Best Places to Work' by Boston Business Journal

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based business sectors,...


May 20, 2019, 08:00 ET MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

MilliporeSigma today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. The...


Mar 20, 2019, 05:30 ET MilliporeSigma Opens First M Lab™ Collaboration Center in Europe

MilliporeSigma today officially opened its new M Lab™ Collaboration Center in Molsheim, France. The center is MilliporeSigma's first in Europe and...


Mar 19, 2019, 06:30 ET MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding with GenScript for a strategic alliance focusing on plasmid...


Mar 04, 2019, 08:00 ET MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed MilliporeSigma's patent application directed...


Feb 19, 2019, 08:00 ET MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

MilliporeSigma, a leader in genome editing, today announced that the United States Patent and Trademark Office has issued a formal notice allowing...


Dec 10, 2018, 11:30 ET MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based...


Nov 27, 2018, 08:00 ET MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

MilliporeSigma today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring the 100 most innovative and...


Nov 05, 2018, 10:00 ET MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Improvements

MilliporeSigma today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified...


Oct 04, 2018, 08:00 ET MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil

MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region. The center will...


Aug 15, 2018, 08:00 ET MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma today announced that the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases....


Jun 05, 2018, 08:00 ET MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization

MilliporeSigma today officially opened North America's first BioReliance® End-to-End Biodevelopment Center providing cell line development services,...


May 16, 2018, 08:00 ET MilliporeSigma to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

MilliporeSigma, a leader in genome editing, today announced a collaboration with Washington University in St. Louis that could lead to the optimizing ...


Apr 23, 2018, 08:00 ET MilliporeSigma Receives Patent for CRISPR Technology in China

MilliporeSigma, a leader in genome editing, today announced that the Chinese Patent Office has issued a notice granting MilliporeSigma's patent...


Feb 20, 2018, 06:30 ET MilliporeSigma Receives Two More Patents for CRISPR Technology

MilliporeSigma, a leader in genome editing, today announced that the Korean Intellectual Property Office and the Israel Patent Office have each...


Dec 20, 2017, 07:00 ET MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing

MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge,...


Dec 19, 2017, 07:00 ET Singapore's IP Office to Grant MilliporeSigma's Patent Application for CRISPR Technology

MilliporeSigma, a leader in genome editing, today announced that the Intellectual Property Office of Singapore has issued a "Notice of Eligibility...


Dec 11, 2017, 07:00 ET MilliporeSigma Signs Distribution Agreement with Avanti® Polar Lipids

MilliporeSigma today announced that it has entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of the...


Nov 01, 2017, 02:00 ET MilliporeSigma and Samsung BioLogics to Extend Strategic Alliance

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on...


Oct 19, 2017, 02:00 ET MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization

MilliporeSigma today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy...


Oct 11, 2017, 08:00 ET MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration

MilliporeSigma today officially opened its new Life Science Center in Burlington, Massachusetts. The new center serves as a regional hub for...


Oct 10, 2017, 18:06 ET Interview Opportunity: Curiosity Cube™ Arrives in Burlington, Governor Charlie Baker to Attend

WHO: MilliporeSigma, a global life science company with its new Greater Boston Hub of approximately 1,300 employees, along with ~50 students from...


Oct 10, 2017, 12:45 ET MilliporeSigma Hosts Leading Scientists at Life Science Symposium in Greater Boston

MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities...